Tags

Type your tag names separated by a space and hit enter

A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine.
Pediatr Infect Dis J. 2009 Apr; 28(4):335-7.PI

Abstract

After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 years postvaccination. The inclusion of rabies vaccine in the expanded program on immunization should be considered in rabies endemic countries.

Authors+Show Affiliations

Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. tmkps@mahidol.ac.thNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

19333080

Citation

Pengsaa, Krisana, et al. "A Three-year Clinical Study On Immunogenicity, Safety, and Booster Response of Purified Chick Embryo Cell Rabies Vaccine Administered Intramuscularly or Intradermally to 12- to 18-month-old Thai Children, Concomitantly With Japanese Encephalitis Vaccine." The Pediatric Infectious Disease Journal, vol. 28, no. 4, 2009, pp. 335-7.
Pengsaa K, Limkittikul K, Sabchareon A, et al. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. Pediatr Infect Dis J. 2009;28(4):335-7.
Pengsaa, K., Limkittikul, K., Sabchareon, A., Ariyasriwatana, C., Chanthavanich, P., Attanath, P., & Malerczyk, C. (2009). A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. The Pediatric Infectious Disease Journal, 28(4), 335-7. https://doi.org/10.1097/INF.0b013e3181906351
Pengsaa K, et al. A Three-year Clinical Study On Immunogenicity, Safety, and Booster Response of Purified Chick Embryo Cell Rabies Vaccine Administered Intramuscularly or Intradermally to 12- to 18-month-old Thai Children, Concomitantly With Japanese Encephalitis Vaccine. Pediatr Infect Dis J. 2009;28(4):335-7. PubMed PMID: 19333080.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. AU - Pengsaa,Krisana, AU - Limkittikul,Kriengsak, AU - Sabchareon,Arunee, AU - Ariyasriwatana,Churdchoo, AU - Chanthavanich,Pornthep, AU - Attanath,Phanosri, AU - Malerczyk,Claudius, PY - 2009/4/1/entrez PY - 2009/4/1/pubmed PY - 2009/5/21/medline SP - 335 EP - 7 JF - The Pediatric infectious disease journal JO - Pediatr Infect Dis J VL - 28 IS - 4 N2 - After concomitant administration of purified chick embryo cell rabies vaccine and Japanese encephalitis vaccine to toddlers, adequate rabies and Japanese encephalitis virus neutralizing antibodies concentrations were demonstrated by day 49, 7 days after a booster at 1 year, and in the majorly at 3 years postvaccination. The inclusion of rabies vaccine in the expanded program on immunization should be considered in rabies endemic countries. SN - 0891-3668 UR - https://www.unboundmedicine.com/medline/citation/19333080/A_three_year_clinical_study_on_immunogenicity_safety_and_booster_response_of_purified_chick_embryo_cell_rabies_vaccine_administered_intramuscularly_or_intradermally_to_12__to_18_month_old_Thai_children_concomitantly_with_Japanese_encephalitis_vaccine_ L2 - https://doi.org/10.1097/INF.0b013e3181906351 DB - PRIME DP - Unbound Medicine ER -